Skip to main content

Rachel Campbell and Callula Nulty

Advanced Clinical Practitioners, Stepping Hill Hospital

A 38-week waiting time was identified for patients who received an IBD diagnosis and were referred to gastroenterology on the general referral pathway, following a referral to the colorectal two-week-wait pathway due to a positive FIT test. This project aimed to develop a direct pathway in order to reduce the wait time for patients.

Patients were switched-off from the two-week-wait pathway and referred, following the pathway criteria, to the gastro Advanced Clinical Practioners (ACPs). It was a joint partnership initiative between ACPs, with the backing of the colorectal surgeons and the business manager. The pathway was trialled for six months, collating data on 58 eligible two-week-wait switch-offs. Of these, 88% were diagnosed with inflammatory bowel disease or microscopic colitis. 69% (40/58) were seen within eight weeks of referral.

The proposed pathway demonstrated its value, particularly for patients with newly diagnosed IBD or microscopic colitis, by enhancing their overall experience. For future development, the pathway will be integrated into the hospital’s patient centre system for ease of use by the colorectal switch-off team.

View poster

Streamlining IBD Diagnosis: Reducing Patient Waiting Times through Collaborative Pathways

IBD STARS is an educational event organised and funded by Tillotts Pharma UK & Ireland, intended for UK & Ireland healthcare professionals. Some of this educational content may contain reference to Tillotts products. PU-03121 | March 2026

Adverse events should be reported. Reporting forms and information in the UK can be found at yellowcard.mhra.gov.uk. Reporting forms and information for Ireland can be found at www.hpra.ie/report-an-issue/medicines-for-human-use/side-effects. Adverse events should also be reported to Tillotts Pharma UK and Ireland. For UK: 01522813500 or uksafety@tillotts.com For Ireland: +353 1 2942015 or pvireland@tillotts.com.